Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
13.43
+0.38 (2.91%)
May 1, 2026, 4:00 PM EDT - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $812.87 million as of May 1, 2026. Its market cap has increased by 82.55% in one year.
Market Cap
812.87M
Enterprise Value
437.65M
1-Year Change
82.55%
Ranking
Category
Stock Price
$13.43
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $812.87M, a decrease of -2.00%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 812.87M | 32.94% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 870.96M |
| Theravance Biopharma | 864.31M |
| Bright Minds Biosciences | 861.94M |
| Arbutus Biopharma | 850.78M |
| ARS Pharmaceuticals | 849.98M |
| Design Therapeutics | 830.68M |
| Relmada Therapeutics | 801.35M |
| SpyGlass Pharma | 799.56M |